| 10.11.16 | Fierce Women in Biopharma 2016

Fierce Women in Biopharma 2016

But while Walmsley may be the first to ascend to a major drugmaker’s CEO chair, she’s far from the first woman to make a major impact on her company, or the industry as a whole. This year, we’re featuring 15 women who are doing just that from a variety of different positions, from CEO to CIO, and everything in between.

As this year’s diverse slate of nominees shows, women are standing out in the field and providing crucial leadership across the board. They’re leading development efforts, anchoring venture funds and overseeing key functions ranging from legal affairs to computing.

And equally importantly, they’re providing mentorship to female and male colleagues alike, assuring that biopharma continues to become--and stays--an industry that values gender diversity, fosters leadership opportunities for women and, yes, even promotes women to its highest offices.

So while Walmsley may break new ground when she slips into the top spot at GSK next March, we’re certain that sooner or later, plenty of others will follow in her footsteps--and that after you read about this year’s impressive group of honorees, you’ll agree.

Find out who made the list and read the full report here >>

©2016 FierceMarkets This email was sent as part of the FierceLifeSci email list which is administered by FierceMarkets, 1900 L Street NW, Suite 400, Washington, DC 20036, (202) 628-8778.

Contact Us
Editor-in-Chief: Tracy Staton. Publisher: Rebecca Willumson.

Advertise
General advertising: Angelique Alcover. Request a media kit.

Email Management
Manage your subscription
Change your email address
Unsubscribe